BofA/Merrill Lynch Upgrades CVS Caremark (CVS) to Buy
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.26 -2.98%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
BofA/Merrill Lynch upgraded CVS Caremark (NYSE: CVS) from Neutral to Buy, citing departure of former CEO from board.
For more ratings news on CVS Caremark click here and for the rating history of CVS Caremark click here.
Shares of CVS Caremark closed at $37.50 yesterday.
For more ratings news on CVS Caremark click here and for the rating history of CVS Caremark click here.
Shares of CVS Caremark closed at $37.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Paramount Skydance extends debt offer deadlines to Aug. 28
- Keefe, Bruyette & Woods Upgrades Nayax (NYAX) to Outperform
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
